Systemic Anti-Cancer Therapy Regimen Library
Colorectal Regimens
Metastatic Regimens
Published
Superseded Regimens
Name
|
Version
|
Date
|
|---|---|---|
| CRC Metastatic - CETUximab [Q1W] and encorafenib | 1.0.2 | 03/03/2024 |
| CRC Metastatic - CETUximab [Q1W] and irinotecan [Q2W] | 2.0.2 | 28/02/2024 |
| CRC Metastatic - CETUximab [Q1W], biNIMEtinib and encorafenib | 1.0.2 | 03/03/2024 |
| CRC Metastatic - CETUximab [Q1W], daBRAFEnib and tRAMEtinib | 1.0.2 | 03/03/2024 |
| CRC Metastatic - mFOLFIRI and CETUximab [Q1W] [high dose foliNIc acid] | 2.0.2 | 28/02/2024 |
| CRC Metastatic - mFOLFIRI and CETUximab [Q1W] [low dose foliNIc acid] | 2.0.2 | 28/02/2024 |
NON-Metastatic Regimens
Published
Anal Regimens
Published
|
Name
|
Version
|
Date
|
|---|---|---|
| CRC ACA - cISplatin and fluorouracil chemoradiation | 1.0.0 | 22/08/2023 |
| CRC ACA - mitomycin and capecitabine chemoradiation | 1.0.0 | 22/08/2023 |
| CRC ACA - mitomycin and fluorouracil chemoradiation | 1.0.0 | 22/08/2023 |
| CRC ACA Advanced - cARBOplatin and PACLItaxel | 1.0.0 | 16/06/2023 |
Rectal Regimens
Published
|
Name
|
Version
|
Date
|
|---|---|---|
| CRC REC Locally advanced - capecitabine chemoradiation [5 day dosing] | 3.0.0 | 07/02/2024 |
| CRC REC Locally advanced - capecitabine chemoradiation [continuous dosing] | 3.0.0 | 07/02/2024 |
| CRC REC Locally advanced - dostarlimab | 1.0.0 | 03/03/2024 |
| CRC REC Locally advanced - fluorouracil chemoradiation | 3.0.0 | 07/02/2024 |
| CRC REC Metastatic - capecitabine chemoradiation [5 day dosing] | 3.0.0 | 13/08/2023 |
| CRC REC Metastatic - capecitabine chemoradiation [continuous dosing] | 3.0.0 | 13/08/2023 |
| CRC REC Metastatic - fluorouracil chemoradiation | 3.0.0 | 13/08/2023 |
| CRC REC Neoadjuvant - RAPIDO Total Neoadjuvant Therapy | 1.0.0 | 03/03/2024 |
| CRC REC Neoadjuvant/Adjuvant - PRODIGE23 Total Neoadjuvant Therapy | 1.0.0 | 30/08/2024 |